ClinicalTrialsFinder

Chimeric Antigen Receptor T-cell Clinical Trials in Xiamen, Fujian

1 recruitingXiamen, Fujian, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Non-Hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University45 enrolled1 locationNCT06875063